-82.3%
CLSK vs CVE
+126.1%
-208.5%
-98.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CVE | Excess | Alpha |
|---|---|---|---|---|
| 1D | +8.5% | -0.6% | +9.0% | +8.6% |
| 7D | -19.7% | -16.1% | -3.6% | -14.9% |
| 30D | -46.5% | -10.4% | -36.1% | -44.6% |
| 3M | -51.7% | -2.4% | -49.3% | -51.5% |
| 6M | -57.5% | -4.4% | -53.1% | -57.4% |
| YTD | -39.1% | +64.9% | -104.1% | -48.9% |
| 1Y | -60.0% | +66.0% | -126.0% | -66.5% |
| 3Y | +42.9% | +57.7% | -14.7% | +20.9% |
| 5Y | -69.9% | +144.7% | -214.7% | -77.6% |
| All | -82.3% | +126.1% | -208.5% | -87.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CVE.
Daily Out/Under-Performance
Portfolio return minus CVE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CVE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling